Document is current
Any future updates will be listed below
-
Authors
Millard, Nghia
Chen, Jonathan H.
Palshikar, Mukta G.
Pelka, Karin
Spurrell, Maxwell
Price, Colles
He, Jiang
Hacohen, Nir
Raychaudhuri, Soumya
Korsunsky, Ilya https://orcid.org/0000-0003-4848-3948
-
Funding
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (5K01AR078355)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (5UC2AR081023)
National Human Genome Research Institute (5U01HG012009)
National Human Genome Research Institute (1R01HG013083)
National Institute of Allergy and Infectious Diseases (5P01AI148102)
Chan Zuckerberg Initiative (DAF2022-249216)
- License Information
-
More Information
Article History
Received: 8 March 2024
Accepted: 21 January 2025
First Online: 25 February 2025
Declarations
:
: Not applicable.
: Not applicable.
: I.K. does bioinformatics consulting for Mestag Therapeutics. S.R. is a founder for Mestag Therapeutics and a scientific adviser for Pfizer, Janssen, and Nimbus Therapeutics. J.H. is a co-founder and stockholder of Vizgen, Inc. K.P. consults for Santa Ana Bio.
